|
|
Clinical effect of low-dose Azithromycin combined with Tiotropium Bromide Inhalation Powder Spray in the treatment of patients with chronic obstructive pulmonary disease in stable phase |
LIU Xing-hua1 YE Zhan-lan1 LI Ai-fen |
1.Department of Respiratory Medicine,Dongguan Hospital of Integrated Traditional Chinese and Western Medicine,Guangdong Province,Dongguan 523000,China;
2.Department of Pharmacy,Dongguan Hospital of Integrated Traditional Chinese and Western Medicine,Guangdong Province,Dongguan 523000,China |
|
|
Abstract Objective To explore the clinical effect of Azithromycin combined with Tiotropium Bromide Inhalation Powder Spray in the treatment of patients with chronic obstructive pulmonary disease in stable phase. Methods Sixty patients with chronic obstructive pulmonary disease in stable phase received treatment from the department of respiratory medicine in our hospital from February 2016 to February 2019 were selected as the research subjects.They were divided into regular group (n=30) and experimental group (n=30) by random number table method.The patients in the regular group were treated with Tiotropium Bromide Inhalation Powder Spray,and the patients in the experimental group were treated with low-dose Azithromycin combiued with Tiotropium Bromide Inhalation Powder Spray.Treatment in each group lasted one month.Oxygen partial pressure,carbon dioxide partial pressure,forced expiratory volume in one second,one-second rate,peak expiratory flow,forced expiratory volume,and the ratio of forced expiratory volume in first second and forced expiratory volume,and therapeutic effect were compared in the two groups. Results After treatment,the oxygen partial pressure level of the experimental group was higher than that of the regular group,and the carbon dioxide partial pressure level was lower than that of the regular group,with statistically significant differences(P<0.05).In the experimental group,the forced expiratory volume in one second,one-second rate,peak expiratory flow,forced expiratory volume,and the ratio of forced expiratory volume in first second and forced expiratory volume were all higher than those in the regular group,and the differences were statistically significant (P<0.05).The total effective rate of the experimental group was higher than that of the regular group,and the difference was statistically significant (P<0.05).Conclusion The treatment of patients with with chronic obstructive pulmonary disease in stable phase by using lowdose Azithromycin combined with Tiotropium Bromide Inhalation Powder Spray can improve the lung function and enhance the therapeutic effect.
|
|
|
|
|
[1] |
包鹤龄,方利文,王临虹,等.1990-2014年中国40 岁及以上人群慢性阻塞性肺疾病患病率Meta 分析[J].中华流行病学杂志,2016,37(1):119-124.
|
[2] |
王青.慢性阻塞性肺疾病与哮喘-慢性阻塞性肺疾病重叠的临床特征及预后分析[J].山西医药杂志,2019,48(19):2398-2400.
|
[3] |
王红娟,郭红荣,鲍敏,等.支气管镜联合无创正压通气治疗慢性阻塞性肺疾病并呼吸衰竭的疗效[J].中国老年学杂志,2016,36(2):377-379.
|
[4] |
杨宁梅,侯颖,王丽,等.综合护理干预在慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭患者中的应用分析[J].中国医药导报,2016,13(1):172-175.
|
[5] |
刘萍,王永斌,高天霖,等.综合性肺康复治疗对稳定期慢性阻塞性肺疾病患者运动能力与生存质量影响[J].中国康复医学杂志,2016,31(8):884-888.
|
[6] |
王慕鹏,蔺红静,张学丽,等.慢性阻塞性肺疾病稳定期的肺康复治疗[J].中国老年学杂志,2019,39(18):4622-4624.
|
[7] |
谷刚,田科.支气管镜联合无创正压通气治疗慢性阻塞性肺疾病并呼吸衰竭的临床疗效[J].中国老年学杂志,2016,36(3):659-660.
|
[8] |
郑亚威,赵宇浩,舒运录,等.传统健身功法联合常规药物治疗稳定期慢性阻塞性肺疾病的Meta 分析[J].广州中医药大学学报,2019,36(6):852-861.
|
[9] |
张媚霞,孙志芬,曲桂红,等.小剂量阿奇霉素联合噻托溴铵治疗老年慢性阻塞性肺疾病的临床疗效观察[J].实用心脑肺血管病杂志,2016,24(7):111-114.
|
[10] |
曹晓琳,熊琴.噻托溴铵粉吸入剂联合不同剂量布地奈德混悬液雾化吸入治疗AECOPD 合并肺部感染的临床观察[J].解放军预防医学杂志,2019,37(4):31-32.
|
[11] |
陈子伟,庄俊合,李耀邦.慢阻肺患者联合应用噻托溴铵粉吸入剂和小剂量阿奇霉素治疗的临床应用效果研究[J].中国现代药物应用,2018,12(10):122-123.
|
[12] |
张卫华.在慢性阻塞性肺疾病稳定期使用布地奈德福莫特罗粉吸入剂和噻托溴铵喷雾剂的疗效观察[J].山西医药杂志,2018,47(18):2170-2172.
|
[13] |
李涛,刘向群,刘景双,等.小剂量阿奇霉素对稳定期老年慢性阻塞性肺疾病患者外周血内TNF-α、IL-8、CRP水平及肺功能的影响[J].中国药物警戒,2016,13(8):460-463.
|
[14] |
范惠明,罗伟.小剂量阿奇霉素对慢阻肺患者TNF-α、IL-8 和CRP 影响及对黏液高分泌抑制作用[J].湖南师范大学学报(医学版),2018,15(1):155-158.
|
[15] |
曹玉华,王亦军,成炜,等.小剂量阿奇霉素联合噻托溴铵粉吸入剂治疗稳定期COPD 临床可行性分析及对炎症细胞因子的影响[J].国际呼吸杂志,2016,36(21):1601-1605.
|
[16] |
赵建美,张艳,邵岩.小剂量阿奇霉素治疗慢性阻塞性肺疾病稳定期的研究进展[J].医学理论与实践,2018,31(20):3028-3029,3014.
|
|
|
|